Inventor
FERRER MARC
US11 patents
⚠️ This page may combine multiple inventors who share the name “FERRER MARC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
4 patentsUS12145922B2Nov 19, 2024
Selective D3 dopamine receptor agonists and methods of their use
US HEALTH0 citations58
US11634404B2Apr 25, 2023
Selective D3 dopamine receptor agonists and methods of their use
US HEALTH0 citations58
US11471460B2Oct 18, 2022
Autophagy modulators for use in treating cancer
US HEALTH1 citations56
US10202367B2Feb 12, 2019
Heterocyclic compounds and methods of use thereof
US HEALTH0 citations47
UNIV JOHNS HOPKINS
3 patentsUS11253511B2Feb 22, 2022
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)
UNIV JOHNS HOPKINS2 citations68
US12208093B2Jan 28, 2025
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)
UNIV JOHNS HOPKINS0 citations58
US11766423B2Sep 26, 2023
2,6-dimethoxy-4-(5-phenyl-4-thiophene-2-yl-1H-imidazol-2-yl)-phenol (DPTIP) a small molecule inhibitor of neutral sphingomyelinase 2 (nSMase-2) for the treatment of neurodegenerative and oncologic diseases
UNIV JOHNS HOPKINS0 citations57
THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES
2 patentsUS12435047B2Oct 7, 2025
c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same
THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES0 citations51
US11649218B2May 16, 2023
C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same
THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES0 citations51